Inventor · disambiguated record
Ana Elena Minatti
Also filed as: MINATTI ANA · MINATTI ANA E · MINATTI ANA ELENA
32 granted patents·13 pending applications·261 citations·filing 2010–2025
97Inventor score
Top patents by PatentIndex Score
45 records- 0198US11993597B2Inhibitors of KRAS G12C and methods of using the sameAMGEN INC·Filed 2022·Granted May 28, 2024·8 cites·50 claims
- 0298US11766436B2KRAS G12C inhibitors and methods of using the sameAMGEN INC·Filed 2021·Granted Sep 26, 2023·11 cites·19 claims
- 0398US11306087B2Inhibitors of KRAS G12C and methods of using the sameAMGEN INC·Filed 2020·Granted Apr 19, 2022·16 cites·55 claims
- 0498US11090304B2KRAS G12C inhibitors and methods of using the sameAMGEN INC·Filed 2019·Granted Aug 17, 2021·33 cites·3 claims
- 0598US10640504B2Inhibitors of KRAS G12C and methods of using the sameAMGEN INC·Filed 2018·Granted May 5, 2020·50 cites·71 claims
- 0697US10988485B2KRAS G12C inhibitors and methods of using the sameAMGEN INC·Filed 2019·Granted Apr 27, 2021·27 cites·51 claims
- 0796US12083121B2Substituted piperazines as KRAS G12C inhibitorsAMGEN INC·Filed 2022·Granted Sep 10, 2024·7 cites·5 claims
- 0896US11285156B2Substituted piperazines as KRAS G12C inhibitorsAMGEN INC·Filed 2019·Granted Mar 29, 2022·16 cites·4 claims
- 0996US9611261B2Perfluorinated cyclopropyl fused 1,3-oxazin-2-amine compounds as beta-secretase inhibitors and methods of useAMGEN INC·Filed 2015·Granted Apr 4, 2017·25 cites·40 claims
- 1095US9085576B2Perfluorinated cyclopropyl fused 1,3-oxazin-2-amine compounds as beta-secretase inhibitors and methods of useAMGEN INC·Filed 2014·Granted Jul 21, 2015·31 cites·60 claims
- 1193US12440491B2KRAS G12C inhibitors and methods of using the sameAMGEN INC·Filed 2023·Granted Oct 14, 2025·1 cites·4 claims
- 1293US10632128B2Compounds that inhibit Mcl-1 proteinAMGEN INC·Filed 2019·Granted Apr 28, 2020·5 cites·49 claims
- 1389US12054476B2KIF18A inhibitorsAMGEN INC·Filed 2021·Granted Aug 6, 2024·1 cites·31 claims
- 1488US2025381187A1Kras g12c inhibitors and methods of using the sameAMGEN INC·Filed 2025·Application pending·0 cites
- 1587US12448396B2Methods of using heterocyclic compounds as Delta-5 Desaturase inhibitorsAMGEN INC·Filed 2022·Granted Oct 21, 2025·1 cites·59 claims
- 1687US11236069B2KIF18A inhibitorsAMGEN INC·Filed 2019·Granted Feb 1, 2022·4 cites·25 claims
- 1785US12509442B2KIF18A inhibitorsAMGEN INC·Filed 2024·Granted Dec 30, 2025·0 cites·32 claims
- 1884US2024287068A1Inhibitors of kras g12c and methods of using the sameAMGEN INC·Filed 2024·Application pending·0 cites
- 1981US8957083B2Spiro-amino-imidazolone and spiro-amino-dihydro-pyrimidinone compounds as beta-secretase modulators and methods of useMINATTI ANA ELENA·Filed 2011·Granted Feb 17, 2015·4 cites·19 claims
- 2081US8921363B2Derivatives of 1 H-isoindol-3-amine, 1 H-iso-aza-indol-3amine, 3,4-dihydroisoquinolin-1-amine, and 1,4-dihydroisoquinolin-3-amine as beta-secretase inhibitorsMINATTI ANA ELENA·Filed 2011·Granted Dec 30, 2014·4 cites·7 claims
- 2180US9556135B2Amino-dihydrothiazine and amino-dioxido dihydrothiazine compounds as beta-secretase antagonists and methods of useAMGEN INC·Filed 2013·Granted Jan 31, 2017·2 cites·38 claims
- 2280US9012446B2Amino-oxazines and amino-dihydrothiazine compounds as beta-secretase modulators and methods of useAMGEN INC·Filed 2013·Granted Apr 21, 2015·4 cites·20 claims
- 2376US8883782B2Spiro-tetracyclic ring compounds as beta-secretase modulators and methods of useCHENG YUAN·Filed 2011·Granted Nov 11, 2014·4 cites·18 claims
- 2475US12459932B2KIF18A inhibitorsAMGEN INC·Filed 2019·Granted Nov 4, 2025·1 cites·34 claims
- 2573US9296759B2Amino-oxazine and amino-dihydrothiazine compounds as beta-secretase modulators and methods of useAMGEN INC·Filed 2012·Granted Mar 29, 2016·2 cites·11 claims
- 2673US9296734B2Perfluorinated 5,6-dihydro-4H-1,3-oxazin-2-amine compounds as beta-secretase inhibitors and methods of useAMGEN INC·Filed 2014·Granted Mar 29, 2016·2 cites·39 claims
- 2772US11224601B1Compounds that inhibits MCL-1 proteinAMGEN INC·Filed 2020·Granted Jan 18, 2022·0 cites·15 claims
- 2870US9777019B2Amino-oxazine and amino-dihydrothiazine compounds as beta-secretase modulators and methods of useAMGEN INC·Filed 2016·Granted Oct 3, 2017·1 cites·13 claims
- 2969US10821115B2Compounds that inhibit Mcl-1 proteinAMGEN INC·Filed 2020·Granted Nov 3, 2020·0 cites·43 claims
- 3069US9550762B2Cyclopropyl fused thiazin-2-amine compounds as beta-secretase inhibitors and methods of useAMGEN INC·Filed 2015·Granted Jan 24, 2017·1 cites·95 claims
- 3163US2021221824A1Heterocyclic compounds as delta-5 desaturase inhibitors and methods of useAMGEN INC·Filed 2021·Application pending·0 cites
- 3262US11512097B2Heterocyclic compounds as Delta-5 desaturase inhibitors and methods of useAMGEN INC·Filed 2020·Granted Nov 29, 2022·0 cites·38 claims
- 3358US2014107109A1Amino-dihydrothiazine and amino-dioxido dihydrothiazine compounds as beta-secretase antagonists and methods of useAMGEN INC·Filed 2013·Application pending·0 cites
- 3454US2024124442A1Tricyclic-amido-bicyclic prmt5 inhibitorsAMGEN INC·Filed 2022·Application pending·0 cites
- 3552US12473289B2Heterocyclic compounds as delta-5 desaturase inhibitors and methods of useAMGEN INC·Filed 2020·Granted Nov 18, 2025·0 cites·10 claims
- 3652US2023159510A1Novel prmt5 inhibitorsAMGEN INC·Filed 2021·Application pending·0 cites
- 3751US2022289724A1Kif18a inhibitorsAMGEN INC·Filed 2020·Application pending·0 cites
- 3848US11279712B2Macrocyclic compounds that inhibit MCL-1 proteinAMGEN INC·Filed 2018·Granted Mar 22, 2022·0 cites·21 claims
- 3947US2015252011A1Perfluorinated cyclopropyl fused 1,3-oxazin-2-amine compounds as beta-secretase inhibitors and methods of useAMGEN INC·Filed 2015·Application pending·0 cites
- 4046US2017267673A1Cyclopropyl fused thiazin-2-amine compounds as beta-secretase inhibitors and methods of useAMGEN INC·Filed 2016·Application pending·0 cites
- 4142US2013158066A14-azaindole inhibitors of cracHOFFMANN LA ROCHE·Filed 2012·Application pending·0 cites
- 4240US2013109720A1Indole inhibitors of cracHOFFMANN LA ROCHE·Filed 2012·Application pending·0 cites
- 4339US2013158040A1Diazaindole inhibitors of cracHOFFMANN LA ROCHE·Filed 2012·Application pending·0 cites
- 4435US8735384B2Amino heteroaryl compounds as beta-secretase modulators and methods of usePARAS NICK A·Filed 2011·Granted May 27, 2014·0 cites·3 claims
- 4535US2011071150A1Indole derivatives as crac modulatorsALAM MUZAFFAR·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Ana Elena Minatti files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →